Dr Raj Kohli, MD

PE-exited Founder | Innovator | Investor | Dyslexic Dad

📍 United Kingdom🔄 Updated September 2026💼 1 investments📅 2 years investing🗓 Last invested Aug 2024
VC🌍 United Kingdom
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
2y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Aug 2024
Ocushield delivers online vision screening for the modern workplace. Helping teams check their eye health in just 4 minutes, anytime, anywhere. Our seamless platform combines digital eye tests with managed eye care vouchers, making it easy for companies to support employee wellbeing while staying compliant, no paperwork, no apps, no hassle.
Experience · 4 entries
All (4)
Investments (1)
Founder (1)
Board (1)
2024
Operating Partner
Aug 2024
Rubix exists to solve a growing and structural problem in modern wealth and investment: Capital increasingly wants to operate directly but lacks the time, bandwidth, and operational capability to do so effectively. Individuals, family offices, and sophisticated investors want the control, learning, and alignment that come with direct investments. Yet most do not have the internal capacity, incentives, or systems to actively manage those investments over time. As portfolios grow more complex, assets quietly drift, governance weakens, and value erodes — often unnoticed until it is too late. Rubix is the operating layer between capital and reality. We translate intent into action, insight into execution, and complexity into clarity. We do not start with capital deployment. We start by solving problems: filtering portfolios, fixing stuck assets, and establishing proper oversight. Capital participation is earned later — not assumed upfront. Rubix is not a fund. Rubix is not a consultancy. Rubix is the missing operating capability modern capital requires. We align ourselves by directly investing with our clients. Please get in touch - investments@rubixventures.co.uk
Board Member
Aug 2024
Ocushield delivers online vision screening for the modern workplace. Helping teams check their eye health in just 4 minutes, anytime, anywhere. Our seamless platform combines digital eye tests with managed eye care vouchers, making it easy for companies to support employee wellbeing while staying compliant, no paperwork, no apps, no hassle.
2015
Founder (exited to Private Equity)
Mar 2015
We use technology to deliver the best healthcare. We share a passion for technology and, together with some of the leading minds in the UK tech industry, we have developed a digital platform that enables direct consultation between customers and doctors via a mobile app. Our obsession is to make digital healthcare accessible to the many rather than the few. We see a world where private healthcare is an affordable and easily accessible service available to everyone. / Partnerships around the world. In the UK we will soon be launching a Video Doctor service for a major pharmacy chain to provide affordable healthcare accessible to anyone who has a smartphone or a laptop. Internationally, we have partnerships in the Caribbean and the Middle East as we follow our ambition to provide high quality healthcare everywhere. Were also developing partnerships with governments to evolve or upgrade existing healthcare infrastructures. This has only been further emphasised by the pressure applied to existing systems through COVID-19. / Adaptable and futureproof technology. The ability of our technology to mature is at the core of our development philosophy enabling us to scale up confidently in the future. We only use the latest software development principles; microservices, agile and continuous innovation. This means we are focused on developing capabilities and features that are relevant so we can respond to variations by region or sector. The combination of medical and digital expertise with the versatility of our platform means we provide a service that is relevant and stays ahead of our competitors. With so many opportunities in digital healthcare, identifying where we channel our focus is our biggest decision. Like all of our decisions, this will be driven by our goal to provide healthcare to as many people who need it, as fast as possible.
2010
Associate
Aug 2010
The American Association of Aesthetic Medicine and Surgery (AAAMS) has been committed to training physicians, registered nurses and practitioners in the art of aesthetics and non-invasive cosmetic surgery through a practical, clear-cut approach with safety in mind since 2006. The AAAMS is the only place where nurses, practitioners and physicians can receive formal cosmetic surgery training in aesthetic medicine and surgery. The rapid demand and acceptance of the public for aesthetic medical services such as dermatology and cosmetic surgery substantiate the importance and the need to standardize aesthetic surgery training. Many untrained practitioners are performing cosmetic surgery procedures without acquiring proper surgery training, knowledge, depth and level of experience that this discipline deserves. Why Choose AAAMS? • Trained over a thousand physicians, nurses and practitioners since 2006 • Offer the most comprehensive wide range of aesthetic courses • Set the global standard in aesthetic medicine and surgery training • Courses provide Continuing Medical Education (CME) credits Aesthetic surgery and non-surgical aesthetic is not a discipline that can be performed without proper training. The AAAMS was developed as a specialty board that can set the standards for cosmetic surgery training. AAAMS courses are hands-on workshops and conferences of consistent matter that represent a comprehensive formal training. The AAAMS serves to set these standards to establish reconstructive, aesthetic surgery and medicine as a separate specialty in the world of medicine. The goal of this association is to ensure uniform excellence in the care of patients. AAAMS continues to serve as the leading internationally recognized association dedicated to the proper teaching of aesthetic medicine and non-surgical procedures.